Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Cartesian Therapeutics (RNAC) Long-Term Debt Issuances (2020)

Historic Long-Term Debt Issuances for Cartesian Therapeutics (RNAC) over the last 1 years, with Q4 2020 value amounting to -$102000.0.

  • Cartesian Therapeutics' Long-Term Debt Issuances changed N/A to -$102000.0 in Q4 2020 from the same period last year, while for Dec 2021 it was -$102000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $24.7 million for FY2020, which is N/A changed from last year.
  • Per Cartesian Therapeutics' latest filing, its Long-Term Debt Issuances stood at -$102000.0 for Q4 2020.
  • Over the past 5 years, Cartesian Therapeutics' Long-Term Debt Issuances peaked at -$102000.0 during Q4 2020, and registered a low of -$102000.0 during Q4 2020.